Allianz Asset Management’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,620
| Closed | -$372K | – | 1719 |
|
|
2023
Q1 | $372K | Buy |
3,620
+1,216
| +51% | +$125K | ﹤0.01% | 1473 |
|
|
2022
Q4 | $352K | Hold |
2,404
| – | – | ﹤0.01% | 1399 |
|
|
2022
Q3 | $406K | Sell |
2,404
-7,005
| -74% | -$1.18M | ﹤0.01% | 1340 |
|
|
2022
Q2 | $1.09M | Buy |
9,409
+1,068
| +13% | +$123K | ﹤0.01% | 1471 |
|
|
2022
Q1 | $832K | Sell |
8,341
-2,634
| -24% | -$263K | ﹤0.01% | 1627 |
|
|
2021
Q4 | $1.71M | Buy |
10,975
+1,677
| +18% | +$262K | ﹤0.01% | 1436 |
|
|
2021
Q3 | $2.19M | Sell |
9,298
-2,040
| -18% | -$481K | ﹤0.01% | 1360 |
|
|
2021
Q2 | $3.85M | Buy |
11,338
+59
| +0.5% | +$20K | ﹤0.01% | 1110 |
|
|
2021
Q1 | $4.56M | Buy |
11,279
+2,122
| +23% | +$858K | ﹤0.01% | 1033 |
|
|
2020
Q4 | $6.09M | Sell |
9,157
-293
| -3% | -$195K | 0.01% | 967 |
|
|
2020
Q3 | $4.4M | Buy |
9,450
+3,801
| +67% | +$1.77M | 0.01% | 1013 |
|
|
2020
Q2 | $3.3M | Buy |
+5,649
| New | +$3.3M | ﹤0.01% | 1118 |
|
|
2019
Q3 | – | Sell |
-2,090
| Closed | -$212K | – | 2257 |
|
|
2019
Q2 | $212K | Buy |
2,090
+43
| +2% | +$4.36K | ﹤0.01% | 2124 |
|
|
2019
Q1 | $269K | Buy |
2,047
+1,181
| +136% | +$155K | ﹤0.01% | 2093 |
|
|
2018
Q4 | $88K | Sell |
866
-959
| -53% | -$97.5K | ﹤0.01% | 2096 |
|
|
2018
Q3 | $456K | Sell |
1,825
-800
| -30% | -$200K | ﹤0.01% | 1917 |
|
|
2018
Q2 | $1.17M | Hold |
2,625
| – | – | ﹤0.01% | 1691 |
|
|
2018
Q1 | $1.04M | Sell |
2,625
-659
| -20% | -$260K | ﹤0.01% | 1708 |
|
|
2017
Q4 | $1.35M | Hold |
3,284
| – | – | ﹤0.01% | 1645 |
|
|
2017
Q3 | $1.42M | Buy |
+3,284
| New | +$1.42M | ﹤0.01% | 1598 |
|